KSV01 Injection

· Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KSV01 Injection, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia [Phase 1]